Alkeon Capital Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-711,777
| Closed | -$9.78M | – | 102 |
|
|
2023
Q1 | $9.78M | Sell |
711,777
-121,464
| -15% | -$1.67M | 0.02% | 85 |
|
|
2022
Q4 | $14.2M | Sell |
833,241
-128,372
| -13% | -$2.18M | 0.05% | 85 |
|
|
2022
Q3 | $21.9M | Sell |
961,613
-72,422
| -7% | -$1.65M | 0.07% | 86 |
|
|
2022
Q2 | $18.6M | Hold |
1,034,035
| – | – | 0.05% | 87 |
|
|
2022
Q1 | $27.6M | Buy |
1,034,035
+95,000
| +10% | +$2.54M | 0.06% | 91 |
|
|
2021
Q4 | $27.5M | Sell |
939,035
-9,762
| -1% | -$286K | 0.05% | 102 |
|
|
2021
Q3 | $62.4M | Sell |
948,797
-102,632
| -10% | -$6.75M | 0.11% | 90 |
|
|
2021
Q2 | $87.5M | Sell |
1,051,429
-2,123
| -0.2% | -$177K | 0.13% | 81 |
|
|
2021
Q1 | $80.8M | Buy |
1,053,552
+2,568
| +0.2% | +$197K | 0.12% | 82 |
|
|
2020
Q4 | $92.8M | Buy |
1,050,984
+122,184
| +13% | +$10.8M | 0.15% | 76 |
|
|
2020
Q3 | $68.6M | Buy |
928,800
+175,000
| +23% | +$12.9M | 0.13% | 78 |
|
|
2020
Q2 | $55M | Buy |
753,800
+270,200
| +56% | +$19.7M | 0.14% | 79 |
|
|
2020
Q1 | $27.2M | Buy |
+483,600
| New | +$27.2M | 0.12% | 79 |
|